Emily Wang

735 total citations
22 papers, 417 citations indexed

About

Emily Wang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Emily Wang has authored 22 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Emily Wang's work include Cancer Genomics and Diagnostics (4 papers), Renal cell carcinoma treatment (3 papers) and Renal and related cancers (3 papers). Emily Wang is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Renal cell carcinoma treatment (3 papers) and Renal and related cancers (3 papers). Emily Wang collaborates with scholars based in United States, Canada and United Kingdom. Emily Wang's co-authors include Feng Chen, Jianbo Xiao, Hui Xu, Mingfu Wang, Judith Wylie‐Rosett, Dimitrios Farmakiotis, Deborah McCue, Dimitrios P. Kontoyiannis, Michael S. Mathisen and Hagop M. Kantarjian and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Clinical Nutrition and Journal of Allergy and Clinical Immunology.

In The Last Decade

Emily Wang

15 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emily Wang United States	10	94	94	81	78	66	22	417
Hannes Datler Austria	6	195 2.1×	70 0.7×	39 0.5×	39 0.5×	43 0.7×	6	537
Guiping Li China	12	113 1.2×	68 0.7×	61 0.8×	47 0.6×	15 0.2×	55	475
Waleed Mohamed Egypt	14	121 1.3×	178 1.9×	112 1.4×	46 0.6×	21 0.3×	33	597
Guipeng An China	14	117 1.2×	112 1.2×	93 1.1×	29 0.4×	29 0.4×	28	558
Zeyuan Lu China	17	344 3.7×	100 1.1×	37 0.5×	68 0.9×	31 0.5×	28	641
Mitra Abbasifard Iran	13	168 1.8×	93 1.0×	29 0.4×	31 0.4×	139 2.1×	56	650
Jiun-Liang Chen Taiwan	14	101 1.1×	41 0.4×	32 0.4×	41 0.5×	24 0.4×	43	427
Antonio Tejera‐Muñoz Spain	13	172 1.8×	58 0.6×	35 0.4×	55 0.7×	78 1.2×	37	547
Abdelhadi M. Shebl Egypt	14	169 1.8×	117 1.2×	64 0.8×	25 0.3×	13 0.2×	40	524
Xuefei Xiao China	14	214 2.3×	164 1.7×	49 0.6×	27 0.3×	64 1.0×	19	561

Countries citing papers authored by Emily Wang

Since Specialization

Citations

This map shows the geographic impact of Emily Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Wang more than expected).

Fields of papers citing papers by Emily Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Wang. The network helps show where Emily Wang may publish in the future.

Co-authorship network of co-authors of Emily Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Wang. A scholar is included among the top collaborators of Emily Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Wang. Emily Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Yeyi, et al.. (2025). Development and validation of case-ascertainment algorithms for hypertensive disorders of pregnancy using longitudinal electronic health records data. Journal of Clinical Epidemiology. 188. 112007–112007.

Zhu, Yeyi, Ana K. Rosen Vollmar, Emily Wang, et al.. (2025). Microbiome-related metabolites in early to midpregnancy and risk of fetal growth extremes: a metabolome-wide association study. American Journal of Clinical Nutrition. 122(5). 1390–1399.

Wang, Emily, et al.. (2025). Hemophagocytic Lymphohistiocytosis (HLH) Following Immune Checkpoint Therapy (ICT). Case Reports in Oncological Medicine. 2025(1). 5582848–5582848.

Donaldson, Scott, et al.. (2025). Association between exposure to digital alcohol marketing and alcohol use: a systematic review and meta-analysis. The Lancet Public Health. 10(11). e912–e922. 1 indexed citations

Johns, Andrew, Matthew T. Campbell, Andrew W. Hahn, et al.. (2024). Efficacy, Safety, and Tolerability of Tivozanib in Heavily Pretreated Patients With Advanced Clear Cell Renal Cell Carcinoma. The Oncologist. 29(7). 589–595. 3 indexed citations

Wang, Emily, Andrew Johns, Matthew T. Campbell, et al.. (2024). Belzutifan Efficacy and Tolerability in Patients with Sporadic Metastatic Clear Cell Renal Cell Carcinoma. European Urology Focus. 11(1). 150–158. 2 indexed citations

Ferrara, Assiamira, et al.. (2024). Racial, Ethnic, and Geographic Differences in Vaginal Birth After Cesarean Delivery in the US, 2011-2021. JAMA Network Open. 7(5). e2412100–e2412100.

Johns, Andrew, Matthew T. Campbell, Zita Dubauskas Lim, et al.. (2024). Efficacy, safety, and tolerability of tivozanib (TIVO) in heavily pretreated patients (pts) with advanced clear-cell renal cell carcinoma (ccRCC).. Journal of Clinical Oncology. 42(4_suppl). 419–419.

Palmer, Kieran, et al.. (2023). The essentials of acute oncology. Clinical Medicine. 23(1). 45–51.

10.

Xu, Hui, Emily Wang, Feng Chen, Jianbo Xiao, & Mingfu Wang. (2021). Neuroprotective Phytochemicals in Experimental Ischemic Stroke: Mechanisms and Potential Clinical Applications. Oxidative Medicine and Cellular Longevity. 2021(1). 6687386–6687386. 88 indexed citations

11.

Dono, Antonio, et al.. (2021). The role of RB1 alteration and 4q12 amplification in IDH-WT glioblastoma. Neuro-Oncology Advances. 3(1). vdab050–vdab050. 13 indexed citations

12.

Dono, Antonio, et al.. (2020). Molecular characteristics and clinical features of multifocal glioblastoma. Journal of Neuro-Oncology. 148(2). 389–397. 29 indexed citations

13.

Kuhn, Theresa, Catherine Finneran, Emily Wang, et al.. (2020). Do High Rates of Atypical Glandular Cells Correlate With Higher Incidence of Disease in a Large Safety Net Hospital. Journal of Lower Genital Tract Disease. 24(4). 353–357.

14.

Gagné, Andréanne, Emily Wang, Nathalie Bastien, et al.. (2019). Impact of Specimen Characteristics on PD-L1 Testing in Non–Small Cell Lung Cancer: Validation of the IASLC PD-L1 Testing Recommendations. Journal of Thoracic Oncology. 14(12). 2062–2070. 47 indexed citations

15.

Wu, Tianying, et al.. (2019). Associations between Dietary Acid Load and Biomarkers of Inflammation and Hyperglycemia in Breast Cancer Survivors. Nutrients. 11(8). 1913–1913. 43 indexed citations

16.

Togias, Alkis, Peter J. Gergen, Jack W. Hu, et al.. (2018). Rhinitis in children and adolescents with asthma: Ubiquitous, difficult to control, and associated with asthma outcomes. Journal of Allergy and Clinical Immunology. 143(3). 1003–1011.e10. 48 indexed citations

17.

Wang, Emily, et al.. (2018). Leflunomide therapy for refractory cytomegalovirus infections in hematopoietic stem cell transplant recipients. Journal of Oncology Pharmacy Practice. 25(7). 1731–1737. 4 indexed citations

18.

Chaer, Firas El, Nobuyoshi Mori, Dimpy P. Shah, et al.. (2016). Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients: A case series. Antiviral Research. 135. 91–96. 10 indexed citations

19.

Wang, Emily, Alison Gulbis, J. W. Hart, & Yago Nieto. (2014). The Emerging Role of Gemcitabine in Conditioning Regimens for Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 20(9). 1382–1389. 6 indexed citations

20.

Wang, Emily & Judith Wylie‐Rosett. (2008). Review of Selected Chinese Herbal Medicines in the Treatment of Type 2 Diabetes. The Diabetes Educator. 34(4). 645–654. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact